Hospital-Level Organ Transplant Recovery at an Illinois LTACH

Yes. RML's multidisciplinary care team is experienced in managing patients on immunosuppressive protocols following organ transplantation. We work in close coordination with the referring transplant centre to maintain medication regimens, monitor for signs of organ rejection, and implement infection prevention measures appropriate to the patient's immunocompromised status. All immunosuppression management at RML is performed under attending physician oversight and in direct alignment with the original transplant programme's care directives, not modified without consultation with the transplant team.

Transfer to an LTACH is appropriate when a transplant patient is stable enough to leave the intensive care unit but still requires hospital-level care, daily physician oversight, and management of ongoing complications, such as respiratory failure, wound infection, renal dysfunction, or nutritional deficiencies, that exceed the capabilities of a skilled nursing facility or lower-acuity post-acute setting. RML's nurse clinical liaisons work directly with ICU discharge planners to assess individual eligibility and coordinate a medically safe, well-supported transfer.

When a patient is transferred to RML Specialty Hospital following organ transplant surgery, our nurse clinical liaisons and attending physicians establish direct communication with the referring transplant programme to maintain continuity of care. This coordination covers immunosuppression protocol management, scheduled laboratory monitoring, communication of clinical changes that warrant transplant team review, and planning for post-discharge outpatient follow-up appointments. RML functions as a clinical extension of the transplant programme, not a standalone recovery facility, ensuring that the care pathway established at the implanting centre is carried forward without interruption throughout the patient's stay.

After organ transplantation, patients on immunosuppressive therapy face elevated risk of opportunistic infections, including bacterial pneumonia, fungal infections such as aspergillosis and candidiasis, urinary tract infections, and surgical site complications. RML Specialty Hospital manages these post-transplant infections with intravenous antibiotic and antifungal therapy, infection isolation protocols where clinically indicated, wound management, and coordination with infectious disease consultants and the referring transplant programme. For transplant patients who develop respiratory failure, RML's ventilator management capabilities provide a level of hospital-level support that is not available in lower-acuity post-acute settings.

Medicare Part A may cover post-transplant recovery at an LTACH like RML Specialty Hospital for patients who meet the qualifying inpatient hospital stay requirement, a minimum of three consecutive inpatient days, and require hospital-level care for ongoing post-surgical complications. Many transplant patients meet these criteria given the complexity of immunosuppression management, infection monitoring, wound care, and renal or respiratory support often required after major organ transplant surgery. RML Specialty Hospital is a Medicare-certified LTACH, and the admissions and financial assistance team is available to assist families and referring providers in confirming eligibility and reviewing coverage and payment options.